Neurology & Neurotherapeutics - NE Outside Agreements

Research Output

Filter
Editorial

200 years after darwin

Rosenberg, R. N., Stüve, O. & Eagar, T., Feb 1 2009, In : Archives of neurology. 66, 2, p. 153-155 3 p.

Research output: Contribution to journalEditorial

1 Scopus citations

A bird's-eye view of T cells during natalizumab therapy

Hohlfeld, R. & Stüve, O., Oct 15 2013, In : Neurology. 81, 16, p. 1372-1373 2 p.

Research output: Contribution to journalEditorial

3 Scopus citations

DNA plasmid vaccination for multiple sclerosis

Stuve, O., Eagar, T. N., Frohman, E. & Cravens, P. D., Oct 1 2007, In : Archives of neurology. 64, 10, p. 1385-1386 2 p.

Research output: Contribution to journalEditorial

5 Scopus citations

Does natalizumab therapy benefit patients with multiple sclerosis?

Stüve, O. & Cutter, G. R., Aug 2014, In : JAMA neurology. 71, 8, p. 945-946 2 p.

Research output: Contribution to journalEditorial

3 Scopus citations

Fine-tuning the homeostasis of regulatory T cells: New mechanism of immunomodulatory therapy in multiple sclerosis

Hofstetter, H. H., Stüve, O. & Hartung, H. P., Nov 1 2008, In : Archives of neurology. 65, 11, p. 1417-1418 2 p.

Research output: Contribution to journalEditorial

2 Scopus citations

Guillain-Barre syndrome: A pediatric challenge

Delgado, M. R., Jan 1 1996, In : Journal of child neurology. 11, 1, p. 1-3 3 p.

Research output: Contribution to journalEditorial

Open Access
8 Scopus citations

Iatrogenic immunosuppression with biologics in MS: Expecting the unexpected?

Stüve, O. & Wiendl, H., Oct 2009, In : Neurology. 73, 17, p. 1346-1347 2 p.

Research output: Contribution to journalEditorial

9 Scopus citations

Immunotherapy for multiple sclerosis: The curious case of interferon beta

Stüve, O. & Ransohoff, R. M., Nov 27 2009, In : Archives of neurology. 66, 10, p. 1193-1194 2 p.

Research output: Contribution to journalEditorial

2 Scopus citations

MTORC1 inhibition for epilepsy in TSC

Sparagana, S. P., Sep 6 2016, In : Neurology. 87, 10, p. 974-975 2 p.

Research output: Contribution to journalEditorial

1 Scopus citations

Natalizumab: Increased vigilance is required in treating patients with multiple sclerosis

Racke, M. K. & Stüve, O., 2008, In : Therapeutic Advances in Neurological Disorders. 1, 3, p. 155-156 2 p.

Research output: Contribution to journalEditorial

2 Scopus citations
Open Access

Neurofilament light chain: An important step toward a disease biomarker in multiple sclerosis

Berger, T. & Stuve, O., Mar 5 2019, In : Neurology. 92, 10, p. 451-452 2 p.

Research output: Contribution to journalEditorial

3 Scopus citations

Neuroinflammation of the central and peripheral nervous system: An update

Stüve, O. & Zettl, U., Mar 1 2014, In : Clinical and Experimental Immunology. 175, 3, p. 333-335 3 p.

Research output: Contribution to journalEditorial

5 Scopus citations

Statins and the blood-brain barrier: Plugging the holes

Stüve, O., Jul 1 2006, In : Annals of Neurology. 60, 1, p. 1-2 2 p.

Research output: Contribution to journalEditorial

3 Scopus citations

Targeting "bad" B cells in multiple sclerosis: Could laquinimod be part of the armamentarium?

Forsthuber, T. G. & Stuve, O., Oct 1 2016, In : Neurology: Neuroimmunology and NeuroInflammation. 3, 5, e283.

Research output: Contribution to journalEditorial

1 Scopus citations
2 Scopus citations

Time to talk about timing - When to start, stop and change anti-migratory drugs in MS

Stüve, O. & Hemmer, B., Nov 2012, In : Multiple Sclerosis Journal. 18, 11, p. 1514-1516 3 p.

Research output: Contribution to journalEditorial

2 Scopus citations

Treatment decisions for patients with active multiple sclerosis

Stüve, O. & Centonze, D., Apr 1 2015, In : JAMA neurology. 72, 4, p. 387-389 3 p.

Research output: Contribution to journalEditorial

3 Scopus citations

Viral pathogens in multiple sclerosis: An intriguing (hi)story

Stüve, O., Racke, M. & Hemmer, B., Oct 1 2004, In : Archives of neurology. 61, 10, p. 1500-1502 3 p.

Research output: Contribution to journalEditorial

13 Scopus citations

Visualizing the cause of gray matter atrophy in multiple sclerosis

Richert, N. D., Kraft, E. & Stüve, O., Feb 1 2009, In : Archives of neurology. 66, 2, p. 159-160 2 p.

Research output: Contribution to journalEditorial